This Week in Psychedelics - 1.7.22

Cannabis

• Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

• Legal recreational marijuana sales begin in Montana (KPAX)

• Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

• New year rings in key changes to state marijuana markets (Marijuana Business Daily)

• GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

• Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

• Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

• The top cannabis research studies of 2021 (Leafly)

• Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

• Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

• Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

• New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

• South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

• Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

• Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

• The cost of medical marijuana in Louisiana (KSLA)

• Israeli startup a go-to resource in medical cannabis world (I24News)

• Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

• Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

• Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

• COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

• New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

• Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

• Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

• Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

• Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

• Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

• IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

• Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

• National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

• Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

• MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

• Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

• Using cannabinoids to treat obesity (Medical Xpress)

• More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

• Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

• PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

• The Promises and Perils of Psychedelic Health Care (The New York Times)

• Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

• Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

• Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

• Psychedelics in 2022: What to Expect (Truffle Report)

• Fact Check-London Mayor not decriminalising drugs (Reuters)

• Psychedelics 2021: A Year in Review (Psilocybin Alpha)

• Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

• Philippines' Duterte says will never apologise for drug war deaths (Reuters)

• New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

• Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

• How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

• Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

• Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

• Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

• Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

• Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

• Startup To Host Psychedelic Trips In The Metaverse (Forbes)

• Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.3.21

Cannabis

• Appeals court rejects lawsuit seeking to force DEA to reschedule marijuana (Marijuana Business Daily)

• Anti-Pot Author Alex Berenson Gets Permanent Twitter Ban (High Times)

• How Much Legal Cannabis Is In California? It’s A State Secret. (Forbes)

• Allowing Public Marijuana Smoking Leads To Bigger NYC Arrest Decline Than In Other Legalized Places (Marijuana Moment)

• Fakkuappu: Japan Struggles with Cannabis Reform (High Times)

• Senators Flooded With Input On Federal Marijuana Legalization Bill (Marijuana Moment)

• Big Pharma Seizes Brazilian Market While Medical Cannabis Bill is Stalled (TalkingDrugs)

• Alabama medical cannabis program might roll out slower than expected (Marijuana Business Daily)

• Swiss Doctors to Prescribe Cannabis Without “Exceptional Authorization” (High Times)

• Legalization Nation: The Dispensary Divide (The Nib)

• New Group Files Another Missouri Marijuana Legalization Initiative For 2022 Ballot (Marijuana Moment)

• Ohio Marijuana Activists Cleared To Collect Signatures For 2022 Legalization Ballot Initiative (Marijuana Moment)

LSD

• How Dock Ellis Made Baseball History on LSD (DoubleBlind)

Magic Mushrooms

• Denver Psychedelics Activists Push To Expand Psilocybin Decriminalization To Allow Gifting And Communal Use (Marijuana Moment)

• Yale researchers discover healing effects of psychedelic drug (Yale Daily News)

• Heroic Hearts Project announces new study with Imperial College London into the physiological and psychological effects of psilocybin on veterans. (Volteface)

• 'Psychedelic renaissance' sees first legal collection of Australia's medicinal magic mushrooms (Australian Broadcasting Corporation)

• The Tragic Story Of Magic Truffles: The Elusive Wild Psilocybe (DoubleBlind)

• Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit (Psilocybin Alpha)

DMT

• Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics (Benzinga)

Ayahuasca

• A single dose of ayahuasca improves self-perception of speech performance in socially anxious people, study finds (PsyPost)

• Wilma Mahua Campos, Shipibo Ayahuasquera (Chacruna)

• The Importance of Traditional Ayahuasca Techniques with Carlos Tanner (EntheoNation)

5-MeO-DMT

• Psychedelic Toads Emerge In Arizona During Monsoon Season (iHeartRadio)

San Pedro

• The Effects of Mescaline in the San Pedro Cactus (The Third Wave)

Novel Psychoactive Substances

• Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Analogs Demonstrate a Significantly Improved Safety Profile in Preclinical Results (Psilocybin Alpha)

Nitrous Oxide

• Nitrous oxide: Patel orders Laughing gas review to decide on potential new law (BBC)

Ketamine

• Cops and Paramedics Involved in Elijah McClain’s Death Charged With Homicide (VICE)

Miscellaneous

• Drug Users Are Suing the Canadian Government Over the War on Drugs (VICE)

• DEA Proposes Massive Increase In Marijuana And Psilocybin Production For Research To Develop FDA-Approved Medicines (Marijuana Moment)

• 'QAnon Shaman' to plead guilty in US Capitol riot case (CNN)

• What Is the ‘Collective Unconscious’ and How Can It Help Us Understand Psychedelic Experiences? (Psychedelics Today)

• Can Psychedelics Promote Social Justice and Change the World? (Chacruna)

• Seattle Should Decriminalize All Drugs, City Task Force On Overdose Crisis Recommends (Marijuana Moment)

• Jon Hopkins Announces New Album Music for Psychedelic Therapy, Shares New Song: Listen (Pitchfork)

• Meet the women who regularly microdose psychedelics (Cosmopolitan)

• Glow Time: PsychLight Brings a Powerful Tool to Psychedelic Research (Psychedelic Science Review)

• New Psychedelic Therapy Clinic Opens in Charleston (Johnson City Press)

• Psychedelics Co. Synthesis Institute Closes $7.25M Series A Funding Through Non-Traditional VC Path (Benzinga)

• Psychedelics—The New Psychiatric Craze (Mad in America)

• Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians (Psilocybin Alpha)

• Psychedelics in Recovery: 12-Step Peer Support Program (Truffle Report)

• Legal Psychedelic Retreats – What They Are & Where to Find Them (EntheoNation)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 3.12.21

Cannabis

• Mexican lawmakers advance bill to legalize recreational cannabis (Leafly)

• Hawaii Senate Approves Marijuana Legalization Bill And Separate Decriminalization Expansion Proposal (Marijuana Moment)

• Virginia Governor Considers Speeding Up Legal Marijuana Timeline (Marijuana Moment)

• South Dakota: Legislative Effort to Delay Implementation of Voter-Approved Medical Marijuana Law Fails (NORML)

• Mississippi House kills medical marijuana bill. Senate tries a hail Mary (Mississippi Today)

• Legislation Introduced To No Longer Deny Citizenship Based on Cannabis Consumption (NORML)

• Thai households now allowed to grow six cannabis plants a year (BusinessLIVE)

• New cannabis coalition wants to influence how — not if — weed is legalized (Politico)

• Rhode Island Senate Leaders Unveil Marijuana Legalization Bill As Governor Prepares Competing Plan (Marijuana Moment)

• Lawmakers In Several States Consider Enacting or Expanding Medical Cannabis Access (NORML)

• Nearly 30,000 Californians Just Had Felony Weed Offenses Reduced to Misdemeanors (MERRY JANE)

• Review: Cannabinoids Effective and Well-Tolerated in Patients with Post-Traumatic Stress (NORML)

• Plymouth Massachusetts Introduces a New Medical Research Website for Cannabis (PR Newswire)

• Indoor Weed Farms Are Hotboxing the Planet (Gizmodo)

• Vaping Weed May Actually Be Worse for Your Lungs Than Smoking Cigarettes, Study Says (MERRY JANE)

LSD

• Psychedelics research: Scientists zero in on the ideal dose of LSD to use in psychiatric treatment (PsyPost)

• LSD Brings Your Brain to the Edge of Chaos (VICE)

• When Acid Makes You Feel Like Jesus (DoubleBlind)

Magic Mushrooms

• New York Lawmaker Files Bill To Decriminalize Psilocybin Mushrooms (Marijuana Moment)

• DEA Sued By Doctor Who Wants Permission To Give Psilocybin Mushrooms To Patients (Marijuana Moment)

• Mind Medicine Australia urges TGA to reverse its Interim Decision on scientific and humanitarian grounds (Mind Medicine Australia)

• Psilocybin Therapy Could Help With Obesity (Baystreet)

• How Red Light Holland Is Bringing Psilocybin Truffles Mainstream (Benzinga)

MDMA

• The impact COVID-19 had on MDMA this festival season (Newshub)

DMT

• DMT and Stroke Research (Truffle Report)

Ayahuasca

• Best Ayahuasca Retreats: How to Choose the Right Ayahuasca Retreat For You (DoubleBlind)

5-MeO-DMT

• Three Friends Explore The Obscure And Potent Substance 5-MeO-DMT In This Existentially Intense Film Doc (Forbes)

Iboga

• Ibogaine Treatment for Trauma (PR Newswire)

Novel Psychoactive Substances

• Is 18-MC a Psychedelic Drug? (Psychedelic Science Review)

Ketamine

• Yes, Ketamine Addiction Is a Thing. Here’s What You Need to Know. (DoubleBlind)

• Intravenous ketamine appears safe, efficacious for adolescents with depression (Healio)

• Lower dose of ketamine is as effective as the standard dose to treat pain in adults (News-Medical.net)

• Best Ketamine Clinics and Therapists: What to Look for if You’re Seeking Ketamine Therapy, and How to Find Ketamine Clinics Near You (DoubleBlind)

Miscellaneous

• Investors Are Debating Who Should Own the Future of Psychedelics (VICE)

• The Race to Patent Psychedelics Is Just Getting Started (VICE)

• Vermont Lawmakers Propose Decriminalizing Drugs (Truffle Report)

• Michigan Activists Launch Statewide Campaign to Decriminalize Entheogenic Plants, Fungi (Truffle Report)

• Why mental health researchers are studying psychedelics all wrong (Salon)

• Report finds people use psychedelic drugs to self-medicate for depression, anxiety and trauma (TheJournal.ie)

• Some Thoughts on For-Profit Psychedelic Startups and Companies (Tim Ferriss)

• An open letter to Tim Ferriss about the value of patents in the psychedelic world (LinkedIn)

• How to Penetrate Clubhouse’s Psychedelic Underground (Lucid News)

• California May Ban Most Employers From Drug Testing People Upon Employment (MERRY JANE)

• Lifetime psychedelic use may reduce likelihood of hypertension (Healio)

• Psychedelic Speech: How Drugs Disorganize Normal Communication Patterns (Psychedelic Science Review)

• New Coalition Seeks Federal Psychedelic Research Funds (Truffle Report)

• The Outlaw Chemists Who Deserve a Cut of the Psychedelic Gold Rush (The New Republic)

• Gurus Behaving Badly: Anaïs Nin’s Diary & the Value of Gossip (Chacruna)

• The Pitfalls and Challenges of Psychedelic Medicine (Psychedelic Science Review)

• Psychedelics and Ancient Art: A History of Confirmation Bias (Truffle Report)

• The Shamanic Persona (Maps of the Mind)

• Psychedelic Science Holds Promise for Mainstream Medicine (UNLV)

• Seeking a True Shaman in the Sierra Mazateca (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 2.26.21

Cannabis

• Murphy signs N.J. legal weed bills, ending 3-year saga (NJ.com)

• North Dakota House votes to legalize recreational marijuana (KXNet.com)

• Alabama Senate passes medical marijuana legislation (WTVM)

• South Dakota: House Members Approve Legislation to Delay Implementation of Voter-Approved Medical Cannabis Law (NORML)

• Virginia OKs smokable flower in move that could spur medical marijuana sales (Marijuana Business Daily)

• Marijuana legalization passes in Minnesota House Committee vote (KIMT)

• Cannabis legalization bill headed to House floor (Albuquerque Journal)

• FDA to include cannabis on essential drugs list (Bangkok Post)

• Virginia Conference Committee Faces Saturday Deadline To Finalize Marijuana Legalization Proposal (Marijuana Moment)

• Pa. lawmakers introduce bipartisan bill to legalize recreational marijuana (WHTM)

• Marijuana legalization proposed in Maryland Legislature (The Washington Post)

• Kansas Governor’s Medical Marijuana Bill Introduced As Lawmakers Take Up Separate Legalization Proposal (Marijuana Moment)

• Colorado families ask for statewide school cannabis access (The Colorado Sun)

• Study: Enactment of Marijuana Legalization Laws Associated with Reductions in Opioid Prescribing Patterns (NORML)

• Legal Marijuana States See Reduced Workers’ Compensation Claims, New Study Finds (Marijuana Moment)

• Missouri pushes back deadline for medical cannabis businesses to open (Marijuana Business Daily)

• Study: Cannabis Mitigates Symptoms in Patients with Treatment-Resistant Fibromyalgia (NORML)

• South Carolina Voters Support Legalizing Medical Marijuana By A Five-To-One Ratio, New Poll Finds (Marijuana Moment)

Magic Mushrooms

• Aion Therapeutic Opening the First International Treatment Center for Psychedelic Psychiatry in Jamaica; Hires Leading Psychiatrist as Medical Director (Psilocybin Alpha)

• Penis Envy Mushrooms: Murder & Conspiracy Behind the World’s Trippiest Shroom (DoubleBlind)

• Red Light Holland, the First Public Candian Psychedelics Company, Is Ready To Sell You Magic Truffles (Lucid News)

MDMA

• MDMA proves a promising alcoholism treatment in world-first trial (New Atlas)

• The Effects of Antidepressant Discontinuation on MDMA-Assisted Psychotherapy (Psychedelic Science Review)

• Root Beer and MDMA: Degrees of Separation (Truffle Report)

DMT

• PharmaDrug Files For FDA Orphan Drug Designation For DMT In Kidney Transplantation and Expands on Its Psychedelics Strategy (Psilocybin Alpha)

• The Ultimate Guide to DMT Pricing (Reality Sandwich)

Iboga

• Ibogaine Addiction Therapy: Then and Now (Truffle Report)

Morning Glory Seeds

• Microdosing LSA: People are Microdosing Acid’s Less Known, Legal Cousin (DoubleBlind)

Synthetic Cannabinoids

• Synthetic cannabis: an unknown gamble with potentially fatal consequences (Stuff.co.nz)

Ketamine

• Elijah McClain's mother relieved he 'is no longer labeled a suspect' after investigation into officers' actions (CNN)

• Aurora, Colorado, to hire independent police monitor after investigation into Elijah McClain's death (KDRV)

• What To Look For When Searching For A Ketamine Clinic (Healing Maps)

PCP

• Rochester police officers involved in suffocation death of Daniel Prude will not face charges (KTLA)

Miscellaneous

• Norway seeks to decriminalise recreational drug use (RTÉ)

• Vermont Introduces Bill to Decriminalize Entheogenic Plants (Truffle Report)

• NYU Langone Health Establishes Center for Psychedelic Medicine (NYU Langone Health)

• Missouri Bill Would Add MDMA, Psilocybin Mushrooms And LSD To Right-To-Try Law (Marijuana Moment)

• Psychedelic Therapy Needs to Confront the Mystical (VICE)

• After a Year of Controversy, MAPS Canada Executive Director Mark Haden Announces Resignation (Psymposia)

• Washington Supreme Court Strikes Down Criminalization Of Drug Possession (Marijuana Moment)

• Casey William Hardison: A Clandestine Chemist’s View on Cognitive Liberty (Filter)

• Why the US Has Embraced Drug Law Reform, But the UK Won't (VICE)

• The Guardian view on illegal drugs: the laws don’t work (The Guardian)

• An Urgent Plea to Users of Psychedelics: Let’s Consider a More Ethical Menu of Plants and Compounds (Tim Ferriss Blog)

• What If We Pay People to Stop Using Drugs? (The New Republic)

• Alexander "Sasha" Shulgin: A Retrospective (Truffle Report)

• The Farmer and The Cowman Should Be Friends: Why the Pharmaceutical Industry and Grassroots Reformists Should Join Forces (Psychedelics Today)

• Microneedle patches for microdosing psychedelic pharmaceuticals (EurekAlert!)

• Meet the Psychedelic Rapper Running for New York City Mayor (DoubleBlind)

• The Case For Psychedelic Couples Counseling (GQ)

• Love and Psychedelic Psychotherapy: Bridging the Divide (Chacruna)

• How Psychedelics Impact Startle Response (Truffle Report)

• The Problem and Paradox of Bad Trips, Part 2 (Psychedelic Science Review)

• Joe Rogan: Dedemonizing Psychedelics (Reality Sandwich)

• Psychedelics, Capitalism, and the Commodification of the Sacred (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.